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Abstract
Background: Regulatory T cells (Tregs) suppress host immune responses and participate in immune homeostasis. In co-
infection, secondary parasite infections may disrupt the immunologic responses induced by a pre-existing parasitic
infection. We previously demonstrated that schistosomiasis-positive (SP) Malian children, aged 4–8 years, are protected
against the acquisition of malaria compared to matched schistosomiasis-negative (SN) children.
Methods and Findings: To determine if Tregs contribute to this protection, we performed immunologic and Treg depletion
in vitro studies using PBMC acquired from children with and without S. haematobium infection followed longitudinally for
the acquisition of malaria. Levels of Tregs were lower in children with dual infections compared to children with malaria
alone (0.49 versus 1.37%, respectively, P=0.004) but were similar months later, during a period with negligible malaria
transmission. The increased levels of Tregs in SN subjects were associated with suppressed serum Th1 cytokine levels, as
well as elevated parasitemia compared to co-infected counterparts.
Conclusions: These results suggest that lower levels of Tregs in helminth-infected children correlate with altered circulating
cytokine and parasitologic results which may play a partial role in mediating protection against falciparum malaria.
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Introduction
Regulatory T cells (Tregs) are a subset of CD4
+ T cells
associated with immunotolerance and appear to play an important
role in modulating the host response to parasites. Co-parasitic
infections such as schistosomiasis and malaria are common in
endemic areas. We and others have shown S. haematobium infection
to modestly protect against uncomplicated malaria in West African
children [1,2]. However, results are mixed when examining the
effect of other helminth infections upon the acquisition of malaria
with some studies suggesting a protective effect [3,4] and others
noting enhanced burden of malarial disease [5–7]. The mecha-
nisms contributing to protection from, or susceptibility to, malaria
remain unclear but there is evidence of immunologic perturbation
in co-infection [8–11]. Given the role of Tregs in immune
homeostasis, we hypothesize that the activity of Tregs in children
infected with S. haematobium may be important in facilitating
protection from malaria.
Tregs are characterized by high expression of CD25 [12,13],
and constitutively express transcription factor forkhead box 3
protein (FOXP3); thought to contribute to differentiation [14,15].
Putative surface markers such as glucocorticoid-induced tumor
necrosis factor receptor (GITR), cytotoxic T-lymphocyte antigen 4
(CTLA-4, CD152), and memory markers have been reported [16–
20]. Based upon cytokine secretion patterns and cell surface
markers, Tregs can be categorized into naturally occurring
(nTregs) and induced/acquired Tregs. Natural T regs are defined
as being FOXP3
+ and thymus-derived, while inducible Tregs
develop in the periphery from conventional CD4
+ T cells after
exposure to regulatory cytokines and other stimuli [19]. However
the lineage relationships and the contribution of other Treg
populations to immune homeostasis is poorly understood and
complicated by the lack of definitive cell markers [21,22].
Little is known about the Treg response to human S. haematobium
infections. Chronic egg-laying schistosomes exert a persistent
stimulatory effect on the host immune system, due in large part to
egg antigens [23,24]. Antigen-specific Treg-associated immuno-
suppression has been described with S. mansoni [25] and other
helminths [26,27]. Recently, Tregs have been suggested to
positively correlate with burden of infection in malaria-negative,
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ison group of children without helminth infection was not included
[28]. In schistosome-infected mice, nTregs suppress effector T cell
response to egg-induced inflammation [29] while adoptive cell
transfer of CD4
+CD25
+ T cells reduce egg-induced liver injury
and enhance survival via an IL-10 pathway [30]. In summary, it
appears that Tregs may ameliorate the robust host immune
response induced by schistosomal egg production.
In malaria, Tregs may facilitate parasitemia and abrogate host
clearance of infection. In vivo depletion of natural CD4
+CD25
+ T
cells prior to infectious challenge with a lethal dose of Plasmodium
spp. results in enhanced mouse survival and eradication of
parasitemia [31,32]. Abrogation of IL-10 and TGF-b response
or depletion of CD4
+CD25
+ Treg cells restores the Th1 cytokine
balance allowing the murine host to control and eradicate the
parasitic infection [31,33]. In humans, Treg induction has been
demonstrated in adults with natural as well as experimental
sporozoite-induced falciparum malaria [34,35] and appears to
correlate with increased clinical malaria [35]. Parasitemia
correlates with a burst of monocyte-derived TGF-b production,
increases in CD3
+CD4
+CD25
hi T cells and FOXP3 expression
[34]. A functional deficit of Tregs has been suggested as one factor
in the inherent protection against falciparum malaria that the
Fulani possess compared to sympatric ethnic groups such as the
Mossi in West Africa [36].
Limited data are available regarding Tregs in co-parasitic
infected humans. Paradoxically, reduced levels of Treg memory
cells were found to be present in Kenyan children co-infected with
S. mansoni and falciparum malaria [37]. Given our findings that the
presence of S. haematobium correlates with protection against
clinical falciparum malaria in an age-specific manner in Malian
children, the role of Tregs as a potential immunologic factor
contributing to this phenomenon was of great interest. The
complexities of conducting immunologic analysis on young
children in remote areas of Africa are well known and, largely
responsible for the paucity of immunologic data. In spite of these
difficulties, we provide evidence that the presence of S. haematobium
in Malian children results in lower Treg levels at the time of a
malaria infection compared to children without helminthic
infection.
Methods
Study population and clinical trial design
Bandiagara (pop. ,13,600) is located in Mali, West Africa and
has intense seasonal transmission (July-December) of P. falciparum
malaria. The entomologic inoculation rate is 20–60 infected bites
per month during peak transmission and, children experience a
mean of 1.54 symptomatic malaria episodes per season [38]. S.
haematobium and mansoni are endemic to the area [39,40] with S.
haematobium prevalence of 25% in children aged 4–14 years and
,50% in adults [1]. This study was conducted over two sequential
malaria transmission seasons (2002-03) and study details have
previously been reported [1,8]. Briefly, children aged 4–14 years of
age, diagnosed as having asymptomatic S. haematobium (SP), were
age, gender and residence-matched to a child without schistoso-
miasis (SN) prior to malaria transmission. Children were followed
weekly over the malaria transmission season (25 weeks) and at a
dry season follow-up appointment (,9 months after enrollment at
a time when standing water pools had dried and schistosoma
transmission had ceased). The primary endpoint of the clinical
trial was time to first clinical malaria infection. Clinic personnel
were available 24 hours-a-day throughout study duration to
detect, examine and treat symptomatic malaria episodes. A
clinical episode of malaria was defined as P. falciparum parasitemia
and axillary temperature $37.5uC on active surveillance, or
parasitemia and symptoms leading to treatment-seeking behavior
in the absence of other clear cause on passive surveillance. All
children were pre-treated with albendazole to eliminate concom-
itant helminth infections and study samples were drawn at the time
of their first clinical malaria episode (or at study week 25/Day 175
in the absence of a clinical infection) and again at the final dry
season appointment. Children were optimally treated for schisto-
somiasis with praziquantel at the final appointment.
Ethics
The trial was conducted in compliance with the Declaration of
Helsinki. Study protocols were reviewed and approved by the
University of Bamako’s Institutional Review Board (IRB) as well as
the University of Maryland IRB. Village permission to conduct
research was obtained from village chiefs, government officials and
traditional healers prior to study initiation. Individual written
informed consent was obtained from the parent or legal guardian
of each child prior to screening and enrollment. All children
displaying gross hematuria or symptoms of genitourinary pathol-
ogy were treated with praziquantel (40 mg/kg) therapy and
discharged from the study.
Sample Collection
Patient whole blood (5–10 mL) was collected at the study clinic
into sterile eppendorf and EDTA tubes on admission, prior to
institution of anti-malarial therapy, and immediately refrigerated.
Sera was processed as previously described [8]. Blood was
processed by density centrifugation, within two hours of
acquisition, utilizing lymphocyte separation medium (ICN Bio-
medical Inc, Aurora, OH) following standard techniques [41].
Peripheral blood mononuclear cells (PBMC) were resuspended in
media and linear-rate frozen using isopropyl alcohol containers
(Nalgene, USA) to 270uC in the field site before transfer in liquid
nitrogen storage containers to the University of Maryland at
Baltimore. Samples for this experiment were chosen based on the
availability of both a wet and dry season time point and the
presence of at least 15.0610
6 cells for each child at each time
point.
PBMC depletion and stimulation
Thawed PBMC were rested overnight at 37uC, 5% CO2 and
washed. A portion of cells (2.0610
6) was removed to serve as
negative (media) and positive (stimulation with 10 mg/ml Staphy-
lococcus enterotoxin B (SEB); Sigma, St. Louis, MO) controls and to
measure the Treg population prior to stimulation. The remaining
PBMC were split into two aliquots consisting of 3.0–4.8610
6 cells
each and either mock-depleted or depleted of CD25
hi cells using
Dynabead pan-mouse IgG or CD25 magnetic beads, respectively
(Invitrogen, Carlsbad, California) at a bead to PBMC ratio of 5:1.
Depleted (mock and CD25
hi) PBMC (3.0610
6) were stimulated
with media, malaria antigen pool (consisting of Apical Membrane
Antigen 1 (AMA1) [42] and Merozoite Surface Protein 1 (MSP142)
[43], and S. haematobium antigen pools (soluble egg antigen (SEA)
and soluble worm antigen protein (SWAP). Antigen stimulation for
the assay was optimized at 5 mg/ml/antigen. The malaria antigens
chosen represent two vaccine candidates being tested at the same
field site in Mali while the S. haematobium antigens are commonly
used in schistosoma research. The 3D7 stain of malaria is well
documented at the Malian site and strain specific protection
against an AMA1 vaccine has been established [44]. AMA1 has
been shown to elicit CMI [45]; however the effect of either malaria
antigen towards Treg induction is unknown. Using an optimized
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transport was blocked by adding 0.5 ml/tube GolgiPlug (BD
Pharmingen) followed by overnight incubation.
Flow Cytometry Staining and Analysis
PBMC were stained with fluorochrome-labeled monoclonal
mouse anti-human antibodies against surface antigens (CD3-
Energy Coupled Dye (ECD, Beckman Coulter, clone UCHT1),
CD4-allophycocyanin (APC)-Cy7 (BD Biosciences, clone SK3),
CD8-Alexa700 (BD Biosciences, clone RPA-T8), CD25-phycoer-
yhtrin (PE)-Cy7 (BD Biosciences, clone M-A251), CD19 (InVitro-
gen, clone SJ25-C1)/Vivid-Pacific Blue, and CD14-biotin (InVi-
trogen, clone Tu ˝K4 followed by streptavidin-Pacific Orange),
followed by fixation/permeabilization by using cytofix/cytoperm
solution (eBiosciences) and intracellular staining with monoclonal
antibodies to IFN-c-APC (BD Biosciences, clone B27), IL-2-PE
(BD Biosciences, clone MQ1-17H12), FOXP3-Alexa488 (eBios-
ciences, clone 236A/E7), and CD69-PE-Cy5 (Beckman Coulter,
clone TP1.55.3). In selected experiments monoclonal antibodies to
IL-10-APC (BD Biosciences, clone JES3-19F1) and TGF-b-PE (IQ
Products, clone TB21) were also used. Cells were then resus-
pended in 1% formaldehyde fixation buffer and analyzed using a
MoFlo flow cytometer/cell sorter system (Beckman Coulter).
PBMC from healthy subjects were used as internal controls in the
experiments. A total of 100,000–800,000 events (mean,500,000)
in the forward and side scatter (FS/SS) lymphocyte gate were
collected per sample. List-mode data files were analyzed using
WinList 6.0 3D (Verity Software House, Topsham, ME). An
amine reactive dye (ViViD, Invitrogen, Oregon) was used as a
dead cell discriminator and B lymphocytes (CD19
+) were excluded
from analysis. Doublets/aggregates were subtracted from analysis
and gate placement determined with the aid of Fluorescence
Minus One (FMO) controls. Cytokine secretion from macrophag-
es/monocytes (CD14
+) was analyzed separately. Specimens were
included in the analysis if (1) the cell viability was .75% after
thawing and (2) cells were shown to be functionally active as
determined by the production of IFN-c by at least 0.2% CD3
+
cells after stimulation with SEB. A response was considered
specific if the differential in the number of positive events between
experimental (stimulated with malaria or schistosoma antigen
pools) and negative control (media) cultures was significantly
increased by x
2 analysis. CD69 has been shown to be upregulated
on activated effector T cells but not Tregs [47]. T regulatory cells
were therefore defined as the population of cells that were
CD3
+CD19
2Vivid
2CD4
+CD25
hiCD69
2FOXP3
+ [34,47]. As
Tregs ameliorate immune responses, enhanced production of
cytokines (IL-2 and IFN-c) should result upon depletion of CD25
hi
within the stimulated PBMC population. A positive response to
Treg cell depletion was defined as (1) The net percentage of
cytokine producing cells was $0.05% in CD25
hi depleted cells as
compared to mock depleted PBMC after subtraction of media
control values; (2) the number of positive events between the
CD25
hi depleted and mock depleted cultures was significantly
increased by x
2 analysis; and (3) the number of positive events in
the stimulant pool compared to the media control in the CD25
hi
depleted cultures was significantly increased by x
2 analysis.
Lymphocyte proliferation assay
If sufficient cells remained, 100,000–150,000 of mock- or
CD25
+-depleted cells/well were plated in triplicates, incubated
with media, anti-CD3
+/CD28
+ beads as a positive control,
malaria or schistosoma pools at 10 mg/ml for 5 days and [
3H]-
thymidine incorporation determined as described [48]. Stimula-
tion indices (SI) were calculated by dividing the mean counts per
minute (cpm) of triplicate wells post-stimulation by the mean cpm
observed in media controls. Values that fell outside the 95% CI of
replicate wells were excluded from analysis. Positive samples were
defined as (1) mean of wells with malarial pools differing
significantly from media controls by paired t-test (one-tailed,
P,0.05), (2) Stimulation index (SI).2 and, (3) mean cpm.1,000
than media control. Stimulation indices were calculated after
[
3H]-thymidine incorporation in PBMC before and after CD25
hi-
depletion and stimulation with malaria and schistosoma antigen at
two time points. Results were excluded if anti-CD3/CD28
stimulated cells failed to exhibit strong response.
Circulating cytokine measurements
Cytokine levels were determined utilizing cytometric bead array
technology (BD Biosciences, San Diego, CA) and fluorescence
detection by flow cytometry following the manufacturer’s
recommendations with modifications, as previously described
[8,49]. The results of individual cytokine levels for only the
volunteers included in this study were examined. These determi-
nations were part of a greater pool of data previously reported [8].
The lower limit of detection was determined to be 2.5–5.0 pg/ml
depending upon the cytokine.
Statistics
Statistical analysis was performed on GraphPad Prism 5
(Graphpad Software, Inc., San Diego, CA) and demographic
and immunologic data were stratified and evaluated by age group
(age 4–8 and 9–14 years). Student t-test (two-tailed) or Mann-
Whitney U test were used to compare continuous data and x
2
analysis, using Mantel-Haenszel or Fisher Exact (two-tailed) as
appropriate, was performed for categorical data. Pearson product-
moment correlation coefficient was calculated utilizing GraphPad
Prism 5. A significance level of P,0.05 was considered statistically
significant.
Results
Sample Population
We previously found that underlying infection with S.
haematobium offered modest but significant clinical protection
against P. falciparum malaria in an age-specific fashion (children
aged 4–8 years) to children exposed to both parasitic infections
[1]. Only samples from children with .15.0610
6 PBMC/time
point (n=52, mean age 8.5 years) were thawed and examined.
Each experiment consisted of a U.S. malaria-naı ¨ve adult control,
an SP child and an age-matched SN child. Evaluative data was
available from 26 SP children (18 of whom developed malaria
(SP Mal) and 8 who did not acquire malaria (SP no Mal) during
the transmission season) and 23 SN children, all of who
developed malaria (SN Mal) (total=49). Very few SN children
remained clinically malaria-free throughout the malaria trans-
mission season and did not have adequate cells to pursue the
immunologic analyses described. Samples were excluded if the
viability or thawed quantity of PBMC was insufficient (n=3 SN
children). SP Mal children had a statistically longer time to first
clinical malaria infection, reduced geometric mean parasite
density at the time of malaria infection, and a trend towards
reduced overall amount of malaria infections detected compared
to age-matched SN Mal children (Table 1). There was no age-
related difference in the character of the malaria infection in SP
children or the amount of schistosoma eggs excreted between SP
Mal children who developed malaria and SP no Mal children in
as i n g l ew e ts e a s o n .
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Paired PBMC samples obtained at two time points (malaria
transmission (wet) and dry season) were examined via multipa-
rameter flow cytometry (Figure 1, a–e). The mean total percentage
of CD3
+CD19
2Vivid
2CD4
+CD25
hiCD69
2FOXP3
+ cells (Tregs)
were significantly higher in SN Mal children at the time of their
malaria infection as compared to matched SP Mal children (1.37
(range 0.28–4.79) vs. 0.49 (0.12–1.28), P=0.004; age 4–14 years)
(Figure 1c). The U.S. malaria-naı ¨ve adult controls (n=5) had a
mean percentage of Tregs of 1.70 (range 0.88–3.84; data not
shown). SP no Mal children had significantly higher mean
percentages of Tregs than SP Mal children [1.12 (range 0.36–
2.47) vs. 0.49 (0.23–1.28), P=0.004]. The mean total percentage
of Tregs in SN Mal children was higher than SP no Mal children
but was not statistically significant (1.37 vs. 1.12, P=0.61). The
percentage of Tregs was statistically equivalent in SN children
compared to SP Mal children after recovery from malaria
infection (i.e., during the dry season follow-up) (1.02 (range 0.2–
2.72) vs. 0.85 (0.2–1.76), P=0.51). Results are also depicted after
age stratification (Figure 1, d and e). The peripheral parasitemia
was compared to the total Treg percentage utilizing Pearson
product correlation (r=0.315, P=0.06).
Intracellular Cytokine Expression to Antigenic
Stimulation
Interleukin-2 and Interferon gamma. Intracellular cytokine
production from PBMC stimulated with pooled malaria and
schistosomal antigens was measured (Table 2 and Figure 2) in 15
SP Mal and 17 SN Mal children (n=32). Three SP no Mal were
excluded from analysis as the parameters of their clinical course did
not match the children who acquired malaria. The majority of
cytokine-producing cells were found to be CD3
+CD19
2CD4
+CD8
2
T cells with minimal levels (,0.03%) observed from both Tregs
(CD3
+CD19
2CD4
+CD8
2CD69
2CD25
hiFOXP3
+) and monocytes/
macrophages (CD3
2CD19
2CD14
+) (data not shown). Significant
cytokine expression was measured after malaria antigen stimulation of
PBMC in both SP children and SN children (Figure 2); however little
difference was noted between the two groups during either the wet or
the dry season (Table 2). When the results were stratified by age,
differences were noted. Very little cytokine expression was measured
in younger children (aged 4–8 years) after PBMC stimulation with the
malaria antigen pool. Significant IL-2 expression was observed in the
majority of older (9–14 years) SP Mal children as compared to age-
matched SN Mal children; a finding that was also noted during the
dry season with the additional finding that significantly more IFN-c
production was also measured. The net percentages of CD4
+ T cells
expressing IL-2 or IFN-c that were statistically significant after
antigenic stimulation as depicted in Figure 2B, C (due to low numbers,
the results of younger and older children were combined). The net
percentage of IL-2 expression was not significantly different in SP Mal
children compared to SN Mal children (net mean percentage: 0.34
(range 0.04–0.98) vs. 0.07 (range 0.04–0.11), P=0.11). A general
trend towards an increased proportion of cytokine secreting cells at the
dry season compared to the wet (malaria transmission) season
(Figure 2b) was seen but was not significant.
Schistosoma antigen recognition was measured with significant
IL-2 and IFN-c expression observed after PBMC stimulation in
the majority of SP children (78% malaria transmission; 82% dry
season) but not in SN children (Table 2). Demonstrable IL-2 and
IFN-cexpression during the wet season was seen in a majority of
older SP children (aged 9–14 years) (7/9 (78%) and 6/9 (67%)
respectively), which was not noted in younger children suggesting
age-associated acquisition of immunity. Of those SP children with
significant cytokine production to schistosoma antigen stimulation,
the net percentages of cytokine expression were 0.44% (range
0.07–1.19) and 0.12% (range 0.07–1.02) for IL-2 and IFN-c,
respectively, during the wet season. The total percentage of
cytokine expression was not significantly different compared to
results measured during the dry season (Figure 2c). Only one
SN child was noted to have detectable IL-2 production after
schistisoma antigen stimulation of PBMC acquired during the wet
season. This 8 year female child had no demonstrable urinary egg
excretion in 3 sequential urine samples prior to the malaria
transmission season and had no evidence of eggs in the urine at
her dry season follow-up. Furthermore, the flow cytometric
analysis on PBMC acquired during the dry season did not
demonstrate enhanced IL-2 production suggesting that the result
may represent a false positive. Malaria-naı ¨ve U.S. adult controls
Table 1. Demographics.
Category Age Strata (years) SP Mal SN Mal P value
Mean age (n) 4–14 8.4 (26) 8.5 (23) ns
4–8 6.3 (15) 6.4 (11) ns
9–14 10.8 (11) 10.9 (12) ns
Female (%) 4–14 8 (30.8) 11 (47.8) ns
Eggs (range)
a 4–14 100 (2–1371) 0 n/a
4–8 62 (2–296) 0 n/a
9–14 144 (2–1371) 0 n/a
Malaria episodes
b (range) 4–14 1.52 (1–4) 2.04 (1–4) 0.06
Days to first malaria episode
b (range) 4–14 76 (49–113) 21.6 (3–40) ,0.0002
Parasitemia
b,c(range) 4–14 4,073 (1,500–47,950) 10,237 (1,000–298,175) 0.03
Demographic characteristics at enrollment and features of subsequent P. falciparum malaria infections of Schistosoma haematobium-positive (SP Mal) and age-matched
S. haematobium-negative (SN Mal) Malian children contributing PBMC for immunologic analysis.
a
aUrinary egg excretion detected in 10 ml of filtered morning (10 am to 2 pm) urine.
bResults for children who did not develop malaria (n=8) are not included these calculations. If no statistical difference was noted between children in the 4–8 year old
category compared to the 9–14 year old category, the results were combined.
cGeometric mean parasite density per mm
3.
doi:10.1371/journal.pone.0031647.t001
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antigen stimulant.
Transforming Growth Factor beta and Interleukin 10
Expression
In selected experiments we examined TGF-b and IL-10
intracellular production after malaria and schistosomal antigen
stimulation in PBMC obtained from 8 SP children (4 SP Mal and
4 SP no Mal) and 6 SN Mal children with malaria, during the wet
and dry season follow-up. Cytokine expression was examined in
cells gated on CD3
+CD4
+CD25
hiFOXP3
+ (Tregs) after antigen
stimulation and, although the numbers were low, it did establish
that detectable cytokine could be measured in these cells (Table
S1). Measureable TGF-b levels were noted after malaria antigenic
stimulation in 50–75% of PBMC in all cohorts during the wet
season and dry season; however the mean percentage of
expression was diminished by the dry season time point. Modest
expression of IL-10 was noted during the wet season but negligible
amounts were detected at follow-up. Only children with detectable
S. haematobium expressed measureable TGF-b after antigenic
stimulation of PBMC with schistosoma antigens, while IL-10
expression was minimal. Malaria-naı ¨ve U.S. adult controls had no
detectable increases in expression of TGF-b or IL-10 from Tregs
following exposure to either antigen.
Depletion Studies
Multiparameter flow cytometry with intracellular
staining. In order to evaluate the effect of Tregs (i.e., CD25
hi
cells) on suppression of CD4
+ T cell cytokine expression, equal
aliquots of PBMC (n=32 individuals) were mock-depleted or
depleted of CD25
hi cells and then stimulated with malaria or
schistosoma antigen pools (n=32). Cytokine expression was then
measured after depletion of CD25
hi cells (compared to the mock-
depleted populations) to determine if cytokine production was
Figure 1. T regulatory cell detection. Quantification of T regulatory cells gated on CD3
+ViViD
2CD19
2CD4
+ with representative plots depicting
the percentage of CD25
hi and FOXP3
+ expression (closed histogram) in (a) a child with S. haematobium and concomitant P. falciparum malaria (SP
Mal) and (b) a child with P. falciparum malaria (SN Mal) alone. The percentages of gated populations are denoted in each filled histogram (a, b).
Region placement was aided by fluorescence minus one (FMO) determinations for CD69
+ and FOXP3
+ cells (open histogram). Dot plots of percentage
of CD3
+ViViD
2CD19
2CD4
+CD69
2CD25
hiFOXP3
+ expression and segregated by group and season are depicted in children (c) aged 4–14 years, (d)
aged 4–8 years and (e) aged 9–14 years. Each dot represents one individual. Bars represent the median and asterisks depict statistically significant
differences between the indicated subset of volunteers and SP children during the transmission season (paired student T test with level of
significance set at P,0.05).
doi:10.1371/journal.pone.0031647.g001
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evaluated by flow cytometry following treatment. Depletion
resulted in removal of 90–95% of detectable CD25
hi. The
results are summarized and a representative experiment is
shown in Table 3 and Figure 3.
After PBMC from wet season samples were depleted of CD25
hi
cells and stimulated with pooled malaria antigen, increased IL-2
and IFN-c expression was noted in 27–43% of experiments
compared to the mock-depleted cells. This finding was noted in
both SP Mal and SN Mal children and across both age groups
(however low numbers preclude definitive statements on statistical
significance). Similarly, increased cytokine expression (29–50%)
was noted in PBMC from the dry season time-point when the
children had recovered from active malaria infection. The PBMC
from children with enhanced IL-2 production after CD25
hi
depletion, with a few exceptions, demonstrated enhanced IFN-c
production in response to depletion. Likewise, PBMC from
children with increased cytokine production after CD25
hi
depletion during the wet season tended to demonstrate the same
findings at the dry season time point. The net percentage of
cytokine increases were measured and there were no significant
differences between any one group or season. No responses were
observed in the SP no Mal children during the malaria
transmission season (n=3) or in the U.S. adult malaria-naı ¨ve
controls.
Increased cytokine expression (compared to mock-depleted PBMC)
was also measured after CD25
hi depletion of PBMC collected from SP
Mal children and stimulated with schistosoma antigen (Table 3,
Figure 3). However, no differences were noted in either the number of
volunteers with increased cytokine production or in the mean net
percentage increase of cytokine between the wet and dry seasons.
Marginal responses were noted in SP no Mal children; however low
numbers preclude definitive conclusions. No responses were observed
in either the SN children or in the U.S. adult malaria-naı ¨ve controls.
We also examined the Treg percentages in those individuals
with enhanced cytokine production after CD25
hi depletion
(responders). No difference was noted between responders and
non-responders. However, the mean percentage of Tregs during
the malaria transmission season in SN Mal responders was
significantly higher than in SP Mal responders (1.19% (range
0.28–4.79) vs. 0.35% (range 0.12–0.68), P=0.004 Mann-Whitney
U test), which mirrored the findings reported for the groups at
large. The mean percentage of Tregs during the wet season for SP
Mal responders was the same as in the dry season (0.35%
compared to 0.41% (range 0.28–0.63) in the same individuals.
Conversely, nearly every SN Mal child responder had higher
Tregs percentage at the time of malaria, as compared to the dry
season (1.19 (0.28–4.79) vs. 0.60% (range 0.2–0.98), P=0.07).
Lymphoproliferative Responses. Of the 26 SP and 23 SN
samples, results were available from 20 SP (12 aged 4–8 years and 8
aged 9–14 years) and 17 SN (11 aged 4–8 years and 7 aged 9–14
years). Results from 6 SP and 6 SN samples were excluded from
analysis due to insufficient cells or inadequate proliferative response
to positive control stimulation. The geometric mean stimulation
indices (SI) for the groups as a whole were quite low in response to
malaria antigen pools (Figure 4a). Eight of the SP (40%) and 6 of the
SN(35%)children had proliferative responses(i.e.,SI$2)tomalaria
antigen stimulation (responders). No differences were noted in
proliferative responses to malaria antigenic pools between the
children with and without S. haematobium or between samples
evaluated during the transmission season and again at a dry season
time point. No differences were noted in SI between mock-depleted
PBMC and anti-CD25
hi-depleted PBMC after stimulation with
malaria antigen (data not shown).
Table 2. Intracellular Cytokine Expression to Antigen Stimulation.
Malaria Antigen Pool
a Schistosoma Antigen Pool
a
Season Cohort Age (yrs) IL-2 (%) P
b IFN-c (%) P
b IL-2 (%) P
b IFN-c (%) P
b
Wet SP 4–8 0/6 (0) ns 1/6 (17) ns 2/6 (33) ns 2/6 (33) ns
SN
c 1/5 (20) 1/5 (20) 1/5 (20)
d 1/5 (20)
d
SP 9–14 7/9 (78) 0.02 4/9 (44) ns 7/9 (78) 0.007 6/9 (67) 0.003
SN 2/10 (20) 3/10 (30) 0/10 (0) 0/10 (0)
SP 4–14 7/15 (47) ns 5/15 (33) ns 9/15 (60) 0.002 8/15 (53) 0.005
SN 3/15 (20) 4/15 (27) 1/15 (7) 1/15 (7)
Dry SP 4–8 2/6 (33) ns 1/6 (17) ns 4/6 (67) 0.06 2/6 (33) ns
SN 4/5 (80) 2/5 (40) 0/5 (0) 0/5 (0)
SP 9–14 6/11 (55) 0.06 7/11 (64) 0.02 9/11 (82) ,0.001 7/11 (64) 0.001
SN 2/12 (17) 2/12 (17) 0/12 (0) 0/12 (0)
SP 4–14 8/17 (47) ns 8/17 (47) 0.16 13/17 (76) ,0.001 9/17 (53) 0.0009
SN 6/17 (35) 4/17 (23) 0/17 (0) 0/17 (0)
Results of intracellular cytokine expression after antigenic stimulation of PBMC acquired from age-matched children with (SP Mal) or without S. haematobium (SN Mal)
during the malaria transmission (wet) season at the time of a malaria episode and again during a dry season follow-up visit. The numerator results represent those
individuals with statistically significant increases in the percentage of cytokine expressed compared to media controls after PBMC stimulation and the denomenator
represents the total number of individual PBMC samples analyzed.
aPBMC were stimulated with a malaria antigen pool (Apical Membrane antigen 1 and Merozoite Surface Protein 1) or with a S. haematobium pool (soluble egg antigen
and soluble worm antigen protein). SP no Mal children were not included in this analysis.
bx
2 analysis, using Mantel-Haenszel or Fisher Exact (two-tailed) as appropriate, was performed between S. haematobium positive (SP Mal) vs. S. haematobium negative
(SN Mal) children in each age category. P value significance set at ,0.05. Not significant = ns.
cThree experiments were excluded due to insufficient or poor viability cell quantities to allow proper interpretation of data.
dIL-2 and IFN-g production was noted in one SN individual. Urine was negative for eggs both at enrollment and at dry season follow-up suggesting a false positive
result.
doi:10.1371/journal.pone.0031647.t002
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during the wet season proliferated after schistosoma antigen
stimulation compared to SN children (13/20 vs. 1/17, p=0.0002,
x
2 analysis) (Figure 4b). Schistosome-specific immunity appeared
to be higher in the dry season. An isolated SI of 3.5 was measured
in an SN child during the transmission season however PBMC
from the dry season did not proliferate suggesting a false positive
result (Table 2). This was not the same child noted to have
intracellular cytokine production to schistosoma antigen stimula-
tion. Again, depletion of CD25
hi PBMC did not result in enhanced
proliferative responses at either time point (data not shown).
Circulating Serum Cytokine Results
Circulating cytokine values were available from prior studies [8].
Data were available for all SP and SN individuals examined by flow
cytometric analysis (Table S2). The mean IFN-c and IL-2 (represen-
tative Th1 cytokines) was significantly reduced in SN children
compared to SP children. Although not statistically significant, reduced
IL-12p70 and IL-6 were similarly noted in SN children. This trend
mirrored the prior analysis. No difference was noted in either IL-4 or in
IL-10 levels (representative Th2 cytokines) between the two groups.
Discussion
Very little is known regarding the activity of Tregs in
individual human parasitic infections or the immunologic
perturbations that one parasitic infection has upon the immune
responsiveness to another infection in the host. We report on the
presence of Tregs in both malaria and S. haematobium infections
and measure antigen-specific cytokine production in response to
malaria and schistosoma antigen stimulation of PBMC acquired
from Malian children. While the limited data published to date
suggests that Tregs are elevated in acute malaria, the effect of S.
haematobium is unknown. Our studies in Malian children provide
strong evidence that the presence of Tregs at the time of an acute
falciparum malaria infection is paradoxically reduced in the
presence of an underlying schistosoma infection compared to age-
matched children without helminth infection. Indirect evidence
supports this paradoxical finding in that children with higher
percentages of Treg (SN Mal) have 1) reduced circulating Th1
(IFN-c and IL-2) serum cytokine levels suggesting effector T cell
suppression; and 2) elevated parasitemia levels compared to their
matched co-infected (SP Mal) counterparts. We did not see
marked differences in Th2 cytokines (e.g., IL-4, IL-10) which
have been shown to be produced by inducible Tregs and limit
malaria pathogenicity [50]. We did not observe an elevation in
Tregs as one might expect to a helminth infection. Surprisingly
little is known about Tregs in children with S. haematobium.W h i l e
a recent study reports measuring Treg in children with S.
haematobium, a comparison group of children without schistoso-
miasis was not included [28]. S. haematobium infection may not
stimulate marked Treg elevation. The Treg differences measured
Figure 2. Intracellular cytokine production to malaria and schistosoma antigens. Representative example of intracellular cytokine (IL-2 and
IFN-c) detection in PBMC, from a child with concomitant S. haematobium and P. falciparum infection, in response to both malaria and schistosoma
pooled antigen stimulation and media control for comparison (panel a). Mean intracellular cytokine production from PBMC stimulated with pooled
(b) malaria and (c) schistosoma antigens collected in children aged 4–14 years with (SP Mal) and without S. haematobium (SN Mal) measured during
the transmission and follow-up dry season. Cytokine-producing cells were found to be predominantly CD3
+CD19
2CD4
+CD8
2 T cells. Cytokine
expression is reported as net % cytokine producing cells (stimulant minus media control) and standard deviations.
doi:10.1371/journal.pone.0031647.g002
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infection had been treated.
A signature role of T regulatory cells is to suppress CD4
+ T cells
[51] resulting in reduced inflammatory responses to a variety of
parasites [19,52–55]. We reasoned that removal of Tregs should
result in enhanced intracellular cytokine expression to antigen
stimulation. Increased expression of IL-2 and/or IFN-c was noted
in 30–50% of CD25
hi-depleted PBMC acquired from SP Mal
children at the time of a malaria infection, however this was also
noted in SN Mal children, as well as in a proportion of samples
acquired during the dry season follow up period when the children
did not have active clinical malaria infection. This finding suggests
that Tregs play a partial role in suppressing the immune response
to antigens in a non-specific manner. It is possible that Tregs are
stimulated to increase in response to malaria infection and that
schistosoma co-infection exerts a down-regulatory effect on the
generation of Tregs rather than affecting Treg function per se. In
this case, the removal of any measurable amount of Treg followed
by cell stimulation at any time point might result in a detectable
increase in cytokine expression. It would be important to confirm
this hypothesis by longitudinally following a cohort of children
prior to the development of the malaria infection and after disease
resolution. However, in this trial, we were limited to collecting
small blood volumes in ill children and requiring that specimens
meet high cell numbers and viability threshold at two time points.
The complicated logistics of obtaining PBMC from the large
cohort of children at enrollment precluded the collection of
samples from being drawn prior to the malaria transmission
season.
The effect that a reduction in measurable Tregs in co-infected
children has on clinical malaria remains speculative. In malaria,
Treg-mediated suppression of Th1 responses may aid Plasmodium
spp. to escape from host immune defenses resulting in higher
parasitemias but ultimately protecting against pathogenic respons-
es such as cerebral malaria [31,56]. Our paradoxical findings that
Tregs are reduced in co-infected children, perhaps analogous to
the reduced production of Tregs noted in the West African Fulani
[36], may be of importance in explaining why children with
schistosomiasis were protected from uncomplicated malaria in our
prospective cohort trial. Similar to this trial, CD25
hi-depletion did
not lead to increased proliferative responses to malaria antigen in
our assays [28], whereas other human studies have described
increased proliferative responses in both severe and uncomplicated
malaria cases [34,57]. The Treg percentage of SN children at the
time of malaria was modestly but not significantly elevated
compared to dry season results possibly due to malaria-induced
Treg elevation. We did not detect clinical differences in malaria
signs or symptoms between SP Mal and SN Mal children as a
result of these Treg differences.
There are a few issues in the present study, which deserve
further investigation. We have previously detected sub-patent,
asymptomatic infection during the dry season in children at this
site (unpublished data) but we did not examine dry season samples
for low-level parasitemia as an explanation for why Tregs may
continue to exert suppressive effects on effector responses.
Moreover, we are limited to observations seen to only two malaria
antigens tested. MSP-1 and AMA-1 are being explored as vaccine
candidates in our population and we have extensive experience
with the immunologic responses to these proteins but they
represent a fraction of the malaria protein repertoire. Parasitized
RBCs have been found, subsequent to our analysis, to elicit two
populations of Tregs expressing different amounts of FOXP3 and
may have provided additional interesting results [58]. It remains
unclear why younger children with schistosomiasis demonstrated
greater clinical protection against malaria [1]. Variable malaria
exposure undoubtedly occurs in our population of 4–14 year old
children. Is the reduction of Tregs seen in SP children
contributory towards a protective effect of helminths on the
acquisition of malaria or is it simply an effect related to competing
co-infections, possibly related to immunologic exhaustion or
suppression of Treg recruitment and/or expansion? We did note
that older SP children demonstrated enhanced immunologic
recognition to malaria antigen compared to their age-matched SN
counterparts but this is difficult to interpret in light of our clinical
Table 3. CD25
hi Depletion Assay Results.
Malaria Antigen Pool
b Schistosoma Antigen Pool
b
Cohort
a Season IL-2 (%) Mean %
c (range) IFN-c (%) Mean %
c (range) IL-2 (%) Mean %
c (range) IFN-c (%) Mean %
c (range)
SP no Mal Wet 0/3 (0) - 0/3 (0) - 0/3 (0) - 1/3 (33) -
Dry 0/3 (0) - 0/3 (0) - 0/3 (0) - 0/3 (0) -
SP Mal Wet 4/15 (27) 0.51(0.31–0.83) 6/15 (40) 0.27 (0.05–1.0) 2/15 (13) 0.39 (0.17–0.61) 3/15 (20) 0.39 (0.08–0.84)
Dry 4/14 (29) 0.3 (0.05–0.57) 7/14 (50) 0.13 (0.05–0.49) 3/14 (21) 0.27 (0.05–0.72) 3/14 (21) 0.30 (0.05–0.77)
SN Mal Wet 5/13 (38) 0.3 (0.05–1.23) 4/13 (31) 0.21 (0.05–0.56) n/a - n/a -
Dry 6/14 (43) 0.21 (0.05–0.56) 4/14 (29) 0.16 (0.13–0.23) n/a - n/a -
Results of enhanced cytokine expression to antigenic stimulation after CD25
hi depletion of PBMC followed by antigenic stimulation in comparison to mock-depleted
populations. The numerator represents the number of children with enhanced Interleukin 2 (IL-2) or Interferon-gamma (IFN-c) expression after depletion compared to
mock-depletion. The denominator is the number of children examined. The net percentage of cytokine expressed in CD3
+CD4
+CD8
2 T cells (i.e., depletion results minus
mock-depletion results) after depletion as measured by multiparameter flow cytometry is also depicted in those experiments with significant cytokine expression
increase. Cells were acquired from age-matched children aged 4–14 years with or without S. haematobium during the malaria transmission (wet) season and again
during a dry season follow-up visit. Also depicted are results from SP children who did not acquire malaria (SP no Mal) during the wet season.
aStratification between younger children aged 4–8 years and older children aged 9–14 years revealed no significant difference so results are reported as a combined age
cohort of children aged 4–14 years.
bPBMC were stimulated with a P. falciparum antigen pool (Apical Membrane antigen 1 and Merozoite Surface Protein 1) or with a S. haematobium antigen pool (soluble
egg antigen and soluble worm antigen protein).
cThe mean percentage increase represents the average of the net increase in cytokine production (stimulant wells minus media wells) of those experiments with
statistically significant results. Significance is defined by 1) net percentage of cytokine producing cells $0.05% in CD25hi-depleted compared to mock-depleted PBMC,
2) the number of positive events between depleted and mock-depleted cultures was significant by Chi-square analysis and 3) the number of positive events in the
stimulant pool compared to the media control in depleted cultures was significantly increased.
doi:10.1371/journal.pone.0031647.t003
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and periodically during, the malaria transmission season is
planned to directly address these important unanswered questions.
The definition of what constitutes a Treg cell is a matter of some
debate. While CD25 has been thought to be a definitive marker of
Tregs [12,13], others suggest that CD25, which is upregulated in
activated CD4
+ T cells, is heterogenous in Tregs [57]. Thus, we
focused on a cell subset from the CD4
+CD25
hi population by
removing from analyses CD69
+ cells (a marker of cell activation)
[47] and corroborating that at least 80% of these cells co-expressed
FOXP3, which allowed us to standardize results across many
experiments by eliminating the confounding effects of heteroge-
neous FOXP3 expression by CD4
+CD25
hi cells. Given that the
percentage of FOXP3
+ expression within CD25
hi cells can vary
widely (as low as 10% in some estimates) [57] we feel that our
approach was highly conservative with respect to defining Treg
populations. It is also true that CD4
+FOXP3
+ cells have variable
levels of CD25 expression [59], and the freeze thaw process may
differentially affect cells and alter levels of CD25 expression. We
also recognize that depletion beads bind only to CD25
hi cells
which may result in Tregs remaining after depletion and fail to
eliminate Tregs that are FOXP3
+ alone (16–35% by some
estimates). Thus, results may be underestimated. This may
partially explain why Treg results vary widely in previous studies.
In controlled experiments involving experimental malaria in naı ¨ve
adults, TGF-b production correlated with parasitemia and Tregs
elevation; however this finding was only noted in 50% of
volunteers [34] without explanation as to why the other volunteers
did not mount a Treg response. We also found that depletion
studies resulted in enhanced cytokine production in approximately
one third to one half of experiments without a clear rationale for
the negative results. Clearly, the complexities of Treg induction in
the human immune response to malaria are poorly understood.
In summary, our data provides evidence of a reduction in Tregs
during acute falciparum malaria infections in schistsomiasis-
infected children. Children with falciparum malaria alone had
higher Tregs percentages along with reduced Th1 circulating
cytokine and higher parasitemias compared to age-matched
children with dual malaria and schistosoma infections. These
Th1 cytokines may act to control parasitemia in the short-run
while contributing to malaria pathogenicity over time. Whether
the reduction of Tregs in the co-infected children mediates
protection against acute falciparum malaria remains unclear.
Future studies are needed to further dissect the complexities of
Figure 3. Intracellular cytokine production to malaria and schistosoma antigens after T regulatory cell depletion. Representative
example of intracellular cytokine detection in PBMC, from a child with concomitant S. haematobium and P. falciparum infection, mock or anti-CD25
hi
depleted prior to stimulation with malaria or schistosoma antigenic pools. Removal of regulatory T cells appears to reverse suppressed immunologic
responses resulting in enhanced intracellular IL-2 and IFN-c in the anti-CD25hi depleted cell population. Media controls are included for comparison.
doi:10.1371/journal.pone.0031647.g003
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schistosoma-infected children at the beginning of the malaria
transmission season contribute to malaria protection over time.
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